A) Geodon B) Prolixin C) Risperdal D) Zyprexa
A) Zyprexa B) Clozaril C) Abilify D) Invega
A) Seroquel B) Invega C) Zyprexa D) Abilify
A) Zyprexa B) Risperdal C) Seroquel D) Abilify
A) Abilify B) Risperdal C) Seroquel D) Geodon
A) Quetiapine B) Olanzapine C) Ziprasidone D) Clozapine
A) Ziprasidone B) Aripriprazole C) Paliperidone D) Risperidone
A) Seroquel B) Risperdal C) Geodon D) Clozaril
A) Ziprasidone B) Paliperidone C) Aripiprazole D) Clozapine
A) Risperdone B) Olazapine C) Quetiapine D) Paliperidone
A) Aripiprazole and Paliperidone B) Clozapine and Aripiprazole C) Clozapine and Risperadone D) Risperidone and Paliperidone
A) 4-5 B) 1 C) 2-5 D) 1-3
A) 6 B) 24 C) 18 D) 12
A) TRUE B) FALSE
A) Minimize side effects of medication B) Foster patients' medication compliance C) Prevent relapse into another psychotic episode D) Develop more adaptive coping skills
A) six months after discontinuation of medication B) directly after discontinuation of medication C) several weeks after discontinuation of medication D) one year after discontinuation of medication
A) Thorazine B) Symmetrel C) Clozaril D) Artane
A) tardive dyskinesia more common B) increased effectiveness for positive, negative, and disorganized symptoms C) enhanced efficacy in treatment-resistant patients D) weight gain more common
A) Haloperiodol B) Prochlorperazine C) Clozapine D) Risperidone
A) Anxiolitics B) Anticonvulsants C) Stimulants D) Alcohol
A) Beta blockers B) Merperidine C) Halperiodol D) Alcohol
A) Nicotine B) Anticonvulsants C) Antacids D) Beta blockers
A) SSRIs B) Tricyclic antidepressants C) Beta blockers D) Alcohol
A) TRUE B) FALSE
A) Tobacco use B) Drug holidays C) Alcohol use D) Male gender
A) TRUE B) FALSE
A) High potency antipsychotic drugs present greater risk for the development of tardive dyskinesia. B) The more frequent the dose of the antipsychotic medication, the greater the risk for the development of tardive dyskinesia. C) All antipsychotic drugs but Clozapine present a significant risk for the development of tardive dyskinesia. D) Classic antipsychotic medications present less risk for the development of tardive dyskinesia than atypical antipsychotic medications.
A) Acute dystonia B) Akinesia C) Akathesia D) Ataxia
A) Gynecomastia B) Postural hypotension C) Neuroleptic Malignant Syndrome D) Agranulocytosis
A) FALSE B) TRUE
A) TRUE B) FALSE
A) block D2 receptors in the pituitary gland and decrease prolactin secretion. B) block D2 receptors in the pituitary gland and inhibit prolactin secretion. C) antagonize the normal dopamine-mediated inhibition of prolactin release. D) agonize the normal dopamine-mediated inhibition of prolactin release.
A) hungry hungry hippos B) receptor binding and DA turnover C) neuroendocrine changes D) molecular structure
A) Thioxanthenenes B) Sleepykoaladones C) Phenothiazines D) Butyrophenones
A) Potent; low; higher B) Weak; high; higher C) Weak; high; lower D) Potent; low; lower
A) Hallucinations B) Formal thought disorder C) Anhedonia D) Delusions
A) Endocrine disorders B) All of the above C) Neurological disorders D) Metabolic disorders E) Autoimmune diseases
A) Stimulants B) Opioids C) Hallucinogens D) All of the above E) Alcohol
A) TRUE B) FALSE
A) negative symptoms of Schizophrenia. B) positive symptoms of Schizophrenia. C) All of the above. D) disorganized symptoms of Schizophrenia.
A) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine reuptake. B) blocking post-synaptic dopamine receptors and/or inhibiting dopamine reuptake. C) blocking post-synaptic dopamine receptors and/or inhibiting dopamine release. D) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine release.
A) the drug increases the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. B) the drug reduces the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. C) the drug increases the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. D) the drug reduces the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine.
A) increased tap dancing B) increased rates of synthesis C) increased release of dopamine D) increased rates of firing
A) aliphatics B) piperazines C) piperideines D) thioxanthenes
A) menstrual irregularity B) galactorrhea C) genecomastia D) all of the above
A) Benadryl (diphenhydramine) B) Symmetrel (amantadine) C) Inapsine (droperiodol) D) Artane (trihexphenidyl) E) Cogentin (benztropine)
A) TRUE B) FALSE
A) comparative lack of EPS B) polypharmacy C) superior impact on positive symptoms D) actual impact at the biological level
A) Clozaril B) Abilify C) Invega D) Haldol
A) Geodon B) Risperdal C) Clorazil D) Seroquel |